Jennifer D. Helble

Jennifer D. Helble

Auto-generated profile, based on publicly available information

Jennifer D. Helble

Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2016 in ACS Chemical Biology
Verified
Journal Article
Closed access
ECEmily L. Clark
Emily L. Clark
MEMadhu Emmadi
Madhu Emmadi
KKKatharine L. Krupp
Katharine L. Krupp
APAnanda R. Podilapu
Ananda R. Podilapu
JHJennifer D. Helble
Jennifer D. Helble
DDDanielle H. Dube
Danielle H. Dube

9 February 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RLRebeccah S. Lijek
Rebeccah S. Lijek
JHJennifer D. Helble
Jennifer D. Helble
AOAndrew J. Olive
Andrew J. Olive
KSKyra W. Seiger
Kyra W. Seiger
MSMichael N. Starnbach
Michael N. Starnbach
Significance: Immunopathology after Chlamydia trachomatis infection is the major cause of human suffering associated with this pathogen, yet the immune responses that drive pathology are not well defined. We demonstrate that a mucosal influx of neutrophils and CXCR3-driven CD4 + and CD8 + T cells is required for C. trachomatis pathology and does not contribute to bacterial clearance. Our study decouples immune-mediated pathology from immune-mediated protection for C. trachomatis , which will have important translational implications for the development of vaccines and CXCR3-mediated treatments.

28 April 2020 in mBio
Verified
Journal Article
Open access
PDF file
JHJennifer D. Helble
Jennifer D. Helble
RGRodrigo J. Gonzalez
Rodrigo J. Gonzalez
UAUlrich H. von Andrian
Ulrich H. von Andrian
MSMichael N. Starnbach
Michael N. Starnbach
Chlamydia trachomatisis an important mucosal pathogen that is the leading cause of sexually transmitted bacterial infections in the United States. Despite this, there is no vaccine currently available. In order to develop such a vaccine, it is necessary to understand the components of the immune response that can lead to protection against this pathogen. It is well known that antigen-specific CD4+T cells are critical forChlamydiaclearance, but the contexts in which they are protective or not protective are unknown. Here, we aimed to characterize the importance of gamma interferon production and sensing by T cells and the effects on the immune response toC. trachomatis. Our work here helps to define the contexts in which antigen-specific T cells can be protective, which is critical to our ability to design an effective and protective vaccine againstC. trachomatis.

11 January 2021 in Parasite Immunology
Verified
Journal Article
Closed access
PDF file
JHJennifer D. Helble
Jennifer D. Helble
JMJulie E. McCarthy
Julie E. McCarthy
LHLinden T. Hu
Linden T. Hu

1 January 2019 in iScience
Verified
Journal Article
Open access
JPJoseph S. Park
Joseph S. Park
JHJennifer D. Helble
Jennifer D. Helble
JLJacob E. Lazarus
Jacob E. Lazarus
GYGuanhua Yang
Guanhua Yang
CBCarlos J. Blondel
Carlos J. Blondel
MWMatthew K. Waldor
Matthew K. Waldor
The invasion of Chlamydia trachomatis, an obligate intracellular bacterium, into epithelial cells is driven by a complex interplay of host and bacterial factors. To comprehensively define the host genes required for pathogen invasion, we undertook a fluorescence-activated cell sorting (FACS)-based CRISPR screen in human cells. A genome-wide loss-of-function library was infected with fluorescent C. trachomatis and then sorted to enrich for invasion-deficient mutants. The screen identified heparan sulfate, a known pathogen receptor, as well as coatomer complex I (COPI). We found that COPI, through a previously unappreciated role, promotes heparan sulfate cell surface presentation, thereby facilitating C. trachomatis attachment. The heparan sulfate defect does not fully account for the resistance of COPI mutants. COPI also promotes the activity of the pathogen's type III secretion system. Together, our findings establish the requirement for COPI in C. trachomatis invasion and the utility of FACS-based CRISPR screening for the elucidation of host factors required for pathogen invasion.

1 September 2019 in Cancer Genetics
Verified
Journal Article
Closed access
KHKathleen Hanlon
Kathleen Hanlon
ATAlex Thompson
Alex Thompson
LPLorena Pantano
Lorena Pantano
JHJohn N. Hutchinson
John N. Hutchinson
AAArshed Al-Obeidi
Arshed Al-Obeidi
BCBen A. Croker
Ben A. Croker